SCHEMBL29567195

SCHEMBL29567195

CNC(=O)c1ccc(Cl)c(Oc2cc(-c3c(C)cccc3C)nc(NS(=O)(=O)c3cccc(N)c3)n2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PCTP Q9UKL6 3/20 0.39
▸ PIK3CD O00329 5/20 0.39
▸ PIK3CA P42336 5/20 0.39
▸ PIK3CB P42338 5/20 0.39
▸ PIK3CG P48736 5/20 0.39
▸ PKM P14618 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ LMNA P02545 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ TSHR P16473 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ STARD10 Q9Y365 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ GAA P10253 1/20 0.34
▸ XBP1 P17861 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310526 1.00 PCTP (0.39) PCTPPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL24309276 0.92 TSHR (0.44) PCTPPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL29567146 0.92 TSHR (0.44) PCTPPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL29566650 0.92 FABP4 (0.40) MEN1KMT2ALMNATSHRSMN1; SMN2
SCHEMBL24310281 0.92 FABP4 (0.40) MEN1KMT2ALMNATSHRSMN1; SMN2
SCHEMBL29566953 0.89 PKM (0.42) PCTPPKMRAB9AMEN1KMT2A
SCHEMBL26807091 0.89 PKM (0.42) PCTPPKMRAB9AMEN1KMT2A
SCHEMBL24310290 0.86 ALDH1A1 (0.44) PKMLMNAALDH1A1
SCHEMBL29567166 0.85 TSHR (0.43) PKMMEN1KMT2ALMNAMAPT
SCHEMBL26807089 0.85 TSHR (0.43) PKMMEN1KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback